Pediatric Mechanical Circulatory Support

다국어 초록 (Multilingual Abstract)

Mechanical circulatory support (MCS) in the pediatric heart failure population has a limited history especially for infants,and neonates. It has been increasingly recognized that there is a rapidly expanding population of children diagnosed and living with heart failure. This expanding population has resulted in increasing numbers of children with medically resistant end-stage heart failure. The traditional therapy for these children has been heart transplantation. However, children with heart failure unlike adults do not have symptoms until they present with end-stage heart failure and therefore, cannot safely wait for transplantation. Many of these children were bridged to heart transplantation utilizing extracorporeal membranous oxygenation as a bridge to transplant which has yielded poor results. As such, industry, clinicians, and the government have refocused interest in developing increasing numbers of MCS options for children living with heart failure as a bridge to transplantation and as a chronic therapy. In this review,we discuss MCS options for short and long-term support that are currently available for infants and children with end-stage heart failure.

참고문헌 (Reference)

1 Khan MS, "mechanically bridging patients with a failing cardiac graft to retransplantation an effective therapy?: analysis of the United Network of Organ Sharing database" 31 : 1192-1198, 2012

2 Morales DL, "Use of ventricular assist devices in children across the United States: analysis of 7.5 million pediatric hospitalizations" 90 : 1313-1318, 2010

3 Miller LW, "Use of a continuous- flow device in patients awaiting heart transplantation" 357 : 885-896, 2007

4 Madigan JD, "Time course of reverse remodeling of the left ventricle during support with a left ventricular assist device" 121 : 902-908, 2001

5 Davies RR, "The use of mechanical circulatory support as a bridge to transplantation in pediatric patients: an analysis of the United Network for Organ Sharing database" 135 : 421-427, 2008

6 Rose EA, "The REMATCH trial: rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure" 67 : 723-730, 1999

7 Levin HR, "Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading" 91 : 2717-2720, 1995

8 Slaughter MS, "Results of a multicenter clinical trial with the Thoratec Implantable Ventricular Assist Device" 133 : 1573-1580, 2007

9 Fraser CD Jr, "Prospective trial of a pediatric ventricular assist device" 367 : 532-541, 2012

10 Rossano JW, "Prevalence of heart failure related hospitalizations and risk factors for mortality in pediatric patients: an analysis of a nationwide sampling of hospital discharges" 120 : S586-, 2009

11 Jeewa A, "Outcomes with ventricular assist device versus extracorporeal membrane oxygenation as a bridge to pediatric heart transplantation" 34 : 1087-1091, 2010

12 Cabrera AG, "Outcomes of pediatric patients supported by the HeartMate II left ventricular assist device in the United States" 32 : 1107-1113, 2013

13 Reinhartz O, "Multicenter experience with the thoratec ventricular assist device in children and adolescents" 20 : 439-448, 2001

14 Duncan BW, "Mechanical circulatory support for the treatment of children with acute fulminant myocarditis" 122 : 440-448, 2001

15 Morales DL, "Implantation of total artificial heart in congenital heart disease" 24 : 142-143, 2012

16 Helman DN, "Implantable left ventricular assist devices can successfully bridge adolescent patients to transplant" 19 : 121-126, 2000

17 Padalino MA, "HeartWare ventricular assist device as bridge to transplant in children and adolescents"

18 Uzark K, "Health-related quality of life in children and adolescents with Duchenne muscular dystrophy" 130 : e1559-e1566, 2012

19 Young JB., "Healing the heart with ventricular assist device therapy: mechanisms of cardiac recovery" 71 (71): S210-S219, 2001

20 Miera O, "First experiences with the HeartWare ventricular assist system in children" 91 : 1256-1260, 2011

21 Meliones JN, "Extracorporeal life support for cardiac assist in pediatric patients: review of ELSO Registry data" 84 (84): III168-III172, 1991

22 Wilmot I, "Effectiveness of mechanical circulatory support in children with acute fulminant and persistent myocarditis" 17 : 487-494, 2011

23 Copeland JG, "Cardiac replacement with a total artificial heart as a bridge to transplantation" 351 : 859-867, 2004

24 Morales DL, "Bridging children of all sizes to cardiac transplantation: the initial multicenter North American experience with the Berlin Heart EXCOR ventricular assist device" 30 : 1-8, 2011

25 Almond CS, "Berlin Heart EXCOR pediatric ventricular assist device for bridge to heart transplantation in US children" 127 : 1702-1711, 2013

26 Slaughter MS, "Advanced heart failure treated with continuous-flow left ventricular assist device" 361 : 2241-2251, 2009

27 Reiss N, "Acute fulminant myocarditis in children and adolescents: the role of mechanical circulatory assist" 52 : 211-214, 2006

28 Morales DL, "A new era: use of an intracorporeal systemic ventricular assist device to support a patient with a failing Fontan circulation" 142 : e138-e140, 2011